VERTEX PHARMACEUTICALS POSTED Q2 REVENUE OF $3.33 BLN, ABOVE THE $3.23 BLN ESTIMATE, WITH ADJUSTED EPS OF $4.73 IN LINE WITH ESTIMATES, EPS OF $4.31 AND ADJUSTED NET INCOME OF $1.21 BLN VERSUS $1.23 | ایران‌آیز

خبر

صفحهٔ اول همهٔ خبرها همهٔ خبرهای ۱۲ مرداد ۱۴۰۵

۱۲ مرداد، ۲۳:۴۳
VERTEX PHARMACEUTICALS POSTED Q2 REVENUE OF $3.33 BLN, ABOVE THE $3.23 BLN ESTIMATE, WITH ADJUSTED EPS OF $4.73 IN LINE WITH ESTIMATES, EPS OF $4.31 AND ADJUSTED NET INCOME OF $1.21 BLN VERSUS $1.23
BLN EXPECTED, AND SEES FY REVENUE OF $13.1 BLN-$13.2 BLN VERSUS $13.07 BLN EXPECTED
متن اصلی؛ ترجمهٔ فارسی ندارد